Michael B Boffa
6PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 07, 2025
Lp(a) as a Risk Factor for Peripheral Artery Disease: Context Is Everything.Marlys L Koschinsky, Michael B Boffa
|Jun 13, 2023
Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme.Justin J W Garabon, Michael B Boffa
|Jan 20, 2022
Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion.Amer Youssef, Justin R Clark, Santica M Marcovina
|May 16, 2019
Simultaneous R2 and quantitative susceptibility mapping measurement enables differentiation of thrombus hematocrit and age: an in vitro study at 3 T.Spencer D Christiansen, Junmin Liu, Michael B Boffa
|Jan 27, 2017
Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment.Zainab A Bazzi, Jennifer Balun, Dora Cavallo-Medved
Pageof 1
